PDS Biotech to Announce Q4 and Year-End Financial Results and Provide Clinical Programs Update on March 30, 2026.

PDS Biotech will host a conference call and webcast on March 30, 2026, at 8:00 am ET to report financial results for the quarter and year ended December 31, 2025. The company will provide a clinical programs and corporate update. PDS Biotech is a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers. Its lead program is in advanced HPV16-positive head and neck squamous cell cancers, and it has initiated a pivotal clinical trial.